Effectiveness of homologous and heterologous BNT162b2 and CoronaVac booster vaccination against severe COVID-19 outcomes

Introduction: Evidence of the waning immunity of coronavirus disease 2019 (COVID-19) primary vaccination, and immune evasion by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has led to the rollout of booster vaccination in many countries. Assessing the effectiveness of b...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Masliyana Husin, Peter Seah Keng Tok, Jing Lian Suah, Boon Hwa Tng, Thevesh Thevananthan, Kalaiarasu M Peariasamy, Sheamini Sivasampu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	The Journal of Infection in Developing Countries 2025-01-01
Edice:	Journal of Infection in Developing Countries
Témata:	SARS-CoV-2 COVID-19 vaccines BNT162b2 CoronaVac booster
On-line přístup:	https://jidc.org/index.php/journal/article/view/18946
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!